drugset / Trial / NCT00579813
Mechanisms Underlying Metabolic Syndrome in Obesity
Phase 4
Completed
70 enrolled
Philip Kern
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · collabNational Institutes of Health (NIH) · collab
Non-randomizedSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to better understand the link between obesity and diabetes or pre-diabetes.
Timeline
- Start
- 2005-04
- Primary completion
- 2009-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pioglitazone | Small molecule | 45 mg | — |